Mechanisms that regulate neurotransmitter receptor aggregation are a prerequisite to concentrate receptors at postsynaptic sites in apposition to axon terminals that release the neurotransmitter. Several of the identified molecules involved in postsynaptic receptor clustering are critical factors in neuronal development, synaptic plasticity, learning and disease.
The originally most well characterized system for ionotropic receptor clustering is the neuromuscular junction, a synapse of an axon terminal of a motoneuron with the muscle fiber plasma membrane (motor end plate). Early studies revealed that contact between motor neuron axons and the myotube surface rapidly triggers the accumulation of preexisting surface acetylcholine receptors (AChRs) (Sanes, 1997) . Furthermore agrin, a presynaptically secreted surface protein, activates postsynaptic signals that lead to AChR clustering by the membrane-associated protein rapsyn (Sanes, 1997) .
In the central nervous system (CNS), ionotropic neurotransmitter receptors are clustered through submembrane postsynaptic multi-protein scaffolds that anchor the transmembrane receptors to the underlying actin cytoskeleton. Prominent examples of the players involved are PSD-95 at glutamatergic or gephyrin at glycinergic and GABAergic synapses. Both factors multimerize and/or connect to a variety of other proteins, for instance via PDZ domain -mediated interactions, that in turn directly or indirectly connect to cytoskeletal elements (Kneussel and Betz, 2000; Sheng and Hoogenraad, 2007) .
The identification of neuronal activityregulated pentraxin (Narp) is one of the few currently known systems that control the synaptic localization of neurotransmitter receptors through extracellular interactions. Narp-expressing HEK293T cells in coculture with neurons induced the aggregation of neuronal AMPA receptors (AMPARs), indicating that Narp functions as an extracellular receptor aggregation factor (O'Brien et al., 1999) .
A new study by Bessereau and coworkers (Gendrel et al., 2009 ) applied the nematode Caenorhabditis elegans to study AChR clustering at cholinergic neuromuscular junctions. This work identified LEV-9 as a novel extracellular protein, secreted by muscle cells, which plays a critical role in extracellular receptor aggregation. The nature of LEV-9, containing eight complement control protein (CCP) domains (sushi domains), suggests a functional connection of synaptic receptor clustering with a new protein family, known as the CCPs. CCPs work in concert to regulate the complement system, involved in clearance of pathogens from an organism, which distinguishes 'self' from 'non-self' via a range of specialized cell-surface and soluble proteins. In any case, the complement system does not exist in nematodes; however, other CCPs mediate defined functions at synapses and in neuronal disease. The authors therefore hypothesize that apart from regulating the immune system, CCPs might in general be important mediators of neuronal functions that remain to be identified. In support of this view, 24 out of 52 mouse genes encoding predicted CCP-domaincontaining proteins are apparently expressed in the CNS (Gendrel et al., 2009) .
Transgenic fusion of lev-9 to a T7 epitope tag sequence identified LEV-9 in a punctate distribution along the ventral and dorsal nerve cords in juxtaposition to cholinergic varicosities and in colocalization with levamisole-sensitive heteromeric AChR (L-AChR) clusters. In contrast, upon disruption of lev-9 in mutant worms, L-AChR staining was no longer detectable, whereas cholinergic presynaptic boutons and the clustering of muscle UNC-49 GABA A receptors remained normal. Notably, as identified by electrophysiological analysis, L-AChRs were located in the plasma membrane, however, with a diffuse distribution. LEV-9 might therefore play a role in receptor clustering without affecting receptor targeting to or from the plasma membrane. GFP-lev-9 was detected in the C. elegans pseudocoelomic cavity and in coelomocytes that filter the pseudocoelomic fluid, indicating that LEV-9 is a secreted protein from body wall muscle cells and most probably localizes in the synaptic cleft.
All strains containing a mutation of the lev-9 locus became resistant to levamisole, a nematode-specific cholinergic agonist that activates AChRs, however, genetic complementation rescued this effect. Either a lev-9 genomic fragment or a lev-9 cDNA specifically expressed in body wall muscle rescued levamisole sensitivity the latter suggesting that LEV-9 expression in muscle is crucial to synaptically cluster AChRs.
In addition to the soluble release factor LEV-9, previous studies by the same group had identified LEV-10 as a critical clustering factor for L-AChRs (Gally et al., 2004) . Although LEV-10 represents a transmembrane protein, it shares several characteristics with LEV-9. LEV-10 is also expressed by C. elegans muscle cells and colocalizes with L-AChRs at cholinergic neuromuscular junctions. Similar to the phenotype of lev-9 mutants, the loss of LEV-10 interferes with receptor clustering, whereas the receptors are correctly targeted and remain in a diffuse manner at the surface membrane of muscle cells.
As previous results had shown that the isolated large extracellular domain of LEV-10 is necessary and sufficient for the clustering activity of this protein, the authors asked whether LEV-9 and LEV-10 might be part of the same extracellular clustering machinery. Indeed, upon the use of an alkaline phosphatase-binding assay, both proteins bound to each other and also colocalized in a discrete punctate pattern, as identified through immunostaining. Furthermore, coimmunoprecipitation identified an interaction between LEV-10 and L-AChRs, thereby suggesting that all three factors participate in an extracellular clustering complex required for L-AChR aggregation at the synapse.
To unravel which factor mediates the dominant clustering activity in the complex, mutant worms were systematically analyzed for the synaptic localization of the binding partners. Unexpectedly, LEV-10 turned out to require the expression of L-AChRs to localize at synapses (Gally et al., 2004) . In lev-9 mutants, the loss in L-AChR clustering was accompanied by a disappearance of synaptic LEV-10 clusters, hence the clustering of LEV-10 requires both LEV-9 and L-AChRs at the neuromuscular junctions. Vice versa, LEV-9 was no longer detectable in animals that did not express LEV-10 or UNC-29 (AChRs), indicating that the three factors are interdependent for synaptic localization.
AChR clustering further critically depends on the intracellular protein rapsyn (Gautam et al., 1995; Sanes, 1997) , however, whether extracellular proteins participate in rapsyn-receptor clustering mechanisms, is currently unknown. The C. elegans protein RPY-1 has been suggested to represent the functional homolog of mammalian rapsyn. Deletion mutants carrying the rpy-1 gene were also resistant to the AChR agonist levamisole and expression of the human rapsyn gene in the muscles of the nematode rpy-1 mutant rescued levamisole resistance (Nam et al., 2009 ). It will therefore be interesting to ask whether intracellular anchoring through the rapsyn/ RPY-1 system functionally crosstalks with extracellular LEV-9/LEV-10 mechanisms.
In general, extracellular systems gain in importance with respect to the localization of plasma membrane proteins. As shown by the laboratories of Gundelfinger and Choquet (Frischknecht et al., 2009) , normal surface membrane diffusion of AMPARs critically depends on an intact extracellular matrix (ECM). This net-like structure participates in the formation of receptor diffusion barriers that underlie processes of surface compartmentalization. Together, the currently described systems for receptor anchoring at synapses act at different levels, (i) the intramembrane level, (ii) the intracellular submembrane level and (iii) the extracellular level (Figure 1 ). Whether these levels represent independent alternative systems or functionally cooperate with each other is subject to current and future investigations. (Silverman et al., 2007) . Scenario 2: intracellular receptor sequences bind to subsynaptic scaffold proteins that indirectly anchor to F-actin. Scenario 3: extracellular factors and/or extracellular domains of transmembrane proteins participate in receptor clustering. LEV-9 and LEV-10 are apparently involved in this mode. Whether they anchor through extracellular or intracellular interactions is currently unknown. Red lines, schematic depiction of molecule interaction forces; receptors, white; other transmembrane proteins, black; intracellular anchoring proteins, black squares; extracellular anchoring protein, black oval; F-actin, diagonal black lines; ECM, extracellular matrix.
